Kenneth M. Kernen, MD, is a partner in, and the director of clinical research for, the Michigan Institute of Urology in Troy. Dr Kernen received his medical degree from Wayne State University School of Medicine in Detroit, Michigan, completed his urologic residency at William Beaumont Hospital in Royal Oak, Michigan, and his urologic oncology fellowship at Baylor College of Medicine in Houston, Texas. He is the chief of urology at William Beaumont Hospital, Troy, where he is also the founding director of the Prostate and Urologic Cancer Multidisciplinary Clinic and clinical chair of the Robotic Surgical Committee. Additionally, he is co-director of the Urology Center for Excellence at Beaumont Health Systems.

Daniel J. George, MD, is a professor of medicine and surgery in the Divisions of Medical Oncology and Urology at Duke University School of Medicine in Durham, North Carolina. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute, where he is the director of genitourinary (GU) oncology. Dr George’s areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. He leads the Duke site for the Department of Defense Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. Dr George is an internationally recognized clinical researcher and thought leader in GU malignancies, with over 150 peer-reviewed publications.

Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 350 clinical trials that focus mainly on GU oncology, has served on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is immediate past president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 150 peer-reviewed publications, several book chapters, and is a peer reviewer for numerous high-impact medical journals. He earned his MD from Duke University Medical School and general surgery/urology residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center.

Mara R. Holton, MD, is the CEO of Anne Arundel Urology group in Annapolis, Maryland, where she has served in this role for the past 5 years. Board-certified by the American Board of Urology and licensed in the state of Maryland, Dr Holton is clinically focused on the care of women’s urological and pelvic floor health. She is the founder and director of the Women’s Wellness Center at Anne Arundel Urology, and is a member of the American Urological Association and the Large Urology Group Practice Association. Dr Holton received her medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania, and completed her surgical and urology training at the University of Maryland Medical Center in Baltimore.

Jason M. Hafron, MD, is a partner and the director of research at the Michigan Institute of Urology, P.C. in Troy; associate professor of urology, William Beaumont School of Medicine, Oakland University; and the director of robotic surgery at Beaumont Hospital Royal Oak. Dr Hafron specializes in the minimally invasive treatment of cancers involving the prostate, kidney, and bladder utilizing laparoscopic and robotic surgery. He received his medical degree from Loyola University Chicago-Stritch School of Medicine, and completed his general surgery and urology residency at Albert Einstein College of Medicine, Montefiore Medical Center. He completed an advanced laparoscopic and robotic surgery fellowship at the Cleveland Clinic Foundation, Glickman Urological and Kidney Institute.

Tamra E. Lewis, MD, FACS, is a private practice urologist at Comprehensive Urologic Care in the suburbs of Chicago. She received her MD from the University of Iowa College of Medicine, completed surgical and urology residencies at the University of Nebraska, and completed a fellowship in female urology and voiding dysfunction at Metro Urology in Minneapolis/St. Paul. Dr Lewis is among the first group of urologists to receive board certifications in female pelvic medicine and reconstructive surgery. Her professional interests include management of incontinence, voiding dysfunction, and urinary tract infections. She is involved organizations that include the American Urological Society, Society of Women in Urology and Chicago Urologic Society, and is a member of the LUPGA Forward Committee.